- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01201382
Depression Prevention Initiative - A Study of Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST) in School Settings
April 5, 2021 updated by: Children's Hospital of Philadelphia
Depression Prevention Initiative - A Study of IPT-AST in School Settings
This study is a randomized controlled trial comparing Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST) to group counseling (GC) for the prevention of depression in adolescents.
The project will: (1) identify adolescents with elevated depressive symptoms but who do not meet criteria for a current mood disorder diagnosis; (2) randomize eligible adolescents to either IPT-AST (N = 100) or GC (N = 100); (3) assess depressive symptoms, depressive disorders, global functioning, interpersonal functioning, comorbid conditions and school related indices at baseline, mid-intervention, post-intervention, and at 6-, 12-, 18-, and 24-month follow-up; (4) examine the effects of IPT-AST on depression and various domains of functioning at each time point; and (5) conduct analyses to examine potential mediators and moderators of the association between IPT-AST and depression outcomes.
This study will yield data on the efficacy of IPT-AST relative to GC for the prevention of depressive symptoms and depressive disorders.
It will also provide information about the mechanisms of action of IPT-AST and determine for whom IPT-AST is most effective.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
185
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Piscataway, New Jersey, United States, 08854
- Rutgers University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19146
- Children's Hospital of Philadelphia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- In 7th-10th grades at intake
- Center for Epidemiologic Studies Depression Scale(CES-D) Score > 16
- At least 2 symptoms on the K-SADS depression section (score of 2 or 3), one of which is either depressed mood, irritability, or anhedonia
- Adolescent must be English-speaking
- Parent speaks English or Spanish
Exclusion Criteria:
- CES-D Score < 15
- Fewer than 2 depression symptoms on the K-SADS (score of 2 or 3) or 2 or more symptoms on the K-SADS with no report of depressed mood, irritability, or anhedonia
- Suicide attempt or self-mutilation in the past year, current active suicidal ideation, and/or history of a clinically significant suicidal behavior (i.e., with intent to die and high medical lethality) or repeated patterns of self-injurious behavior
- Presence of current Major Depressive Disorder, dysthymia, substance abuse, schizophrenia, bipolar disorder, conduct disorder, or psychosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: IPT-AST
Interpersonal Psychotherapy-Adolescent Skills Training
|
A school-based group prevention program that includes 2 individual pre-group sessions, 8 weekly 90 minute group sessions, an individual mid-group session and 4 booster sessions
Other Names:
|
|
Active Comparator: Group Counseling
|
Usual group counseling as delivered by school counselors; 1 pre-group session, 1 mid-group session, 8 90-minute group sessions, 4 booster sessions
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of a Major Depressive Episode, Dysthymia or Depressive Disorder Not Otherwise Specified (NOS) on the Schedule for Affective Disorders for School Aged Children - Present and Life Time Version (K-SADS-PL)
Time Frame: Post intervention (approximately 3 months post baseline)
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation
|
Post intervention (approximately 3 months post baseline)
|
|
Presence of a Major Depressive Episode, Dysthymia or Depressive Disorder NOS on the K-SADS-PL
Time Frame: 6-months post-intervention
|
6-months post-intervention
|
|
|
Presence of a Major Depressive Episode, Dysthymia or Depressive Disorder NOS on the K-SADS-PL
Time Frame: 12-months post-intervention
|
12-months post-intervention
|
|
|
Presence of a Major Depressive Episode, Dysthymia or Depressive Disorder NOS on the K-SADS-PL
Time Frame: 18-months post-intervention
|
18-months post-intervention
|
|
|
Presence of a Major Depressive Episode, Dysthymia or Depressive Disorder NOS on the K-SADS-PL
Time Frame: 24-months post-intervention
|
24-months post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Children's Depression Rating Scale-Revised (CDRS-R)
Time Frame: Post intervention (approximately 3 months after baseline)
|
Scores on the CDRS-R
|
Post intervention (approximately 3 months after baseline)
|
|
Children's Depression Rating Scale-Revised
Time Frame: 6-months post-intervention
|
6-months post-intervention
|
|
|
Children's Depression Rating Scale-Revised
Time Frame: 12-months post-intervention
|
12-months post-intervention
|
|
|
Children's Depression Rating Scale-Revised
Time Frame: 18-months post-intervention
|
18-months post-intervention
|
|
|
Children's Depression Rating Scale-Revised
Time Frame: 24 months post-intervention
|
24 months post-intervention
|
|
|
Children's Global Assessment Scale (CGAS)
Time Frame: Post intervention (approximately 3 months following baseline)
|
Assesses global functioning
|
Post intervention (approximately 3 months following baseline)
|
|
Children's Global Assessment Scale
Time Frame: 6-months post-intervention
|
6-months post-intervention
|
|
|
Children's Global Assessment Scale
Time Frame: 12-months post-intervention
|
12-months post-intervention
|
|
|
Children's Global Assessment Scale
Time Frame: 18-months post-intervention
|
18-months post-intervention
|
|
|
Children's Global Assessment Scale
Time Frame: 24-months post-intervention
|
24-months post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jami F Young, Ph.D., Children's Hospital of Philadelphia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
June 1, 2017
Study Registration Dates
First Submitted
September 13, 2010
First Submitted That Met QC Criteria
September 13, 2010
First Posted (Estimate)
September 14, 2010
Study Record Updates
Last Update Posted (Actual)
April 8, 2021
Last Update Submitted That Met QC Criteria
April 5, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MH087481
- R01MH087481 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on IPT-AST
-
Children's Hospital of PhiladelphiaNational Institute of Mental Health (NIMH); Rutgers UniversityCompletedDepressionUnited States
-
Children's Hospital of PhiladelphiaNational Institute of Mental Health (NIMH); University of Illinois at Urbana-Champaign and other collaboratorsCompleted
-
Children's Hospital of PhiladelphiaThe Klingenstein Third Generation FoundationRecruitingDepressive SymptomsUnited States
-
University of MinnesotaRecruiting
-
Ariston Pharmaceuticals, Inc.UnknownMigraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With AuraFinland, Netherlands, United Kingdom
-
University College, LondonNot yet recruitingInflammation | Periodontal DiseasesUnited Kingdom
-
Chang Gung Memorial HospitalConmed Pharmaceutical & Bio-Medical CorporationRecruitingAcute Kidney Disease | Acute Kidney Injury (AKI)Taiwan
-
Astrogen, Inc.CompletedAutism Spectrum DisorderSouth Korea
-
Tanabe Pharma CorporationKureha CorporationCompletedChronic Kidney DiseaseUnited States, France, Italy, Poland, Ukraine, Mexico, Canada, Brazil, Argentina, Czechia, Puerto Rico, Russia
-
Tanabe Pharma CorporationKureha CorporationCompletedChronic Kidney DiseaseUnited States, Poland, Ukraine, Spain, Mexico, Canada, Brazil, Argentina, Puerto Rico, Germany, Czechia, Russia